3.39

9.84% -0.37

After Hours: 3.50 0.11 +3.24%

Sana Biotechnology Inc (SANA)

Overview News Price History Option Chain Financials Why SANA Down? Discussions Forecast

Sana Biotechnology Inc stock is traded at $3.39, with a volume of 3.63M. It is down -9.84% in the last 24 hours and down -19.86% over the past month. Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.

Previous Close:

$3.76

Open:

$3.5

24h Volume:

3.63M

Relative Volume:

2.74

Market Cap:

$689.64M

Revenue:

Net Income/Loss:

$-283.26M

P/E Ratio:

-1.7937

EPS:

-1.89

Net Cash Flow:

$-273.61M

1W Performance:

-10.32%

1M Performance:

-19.86%

6M Performance:

-67.53%

1Y Performance:

-3.97%

1-Day Range:

$2.85

$3.54

1-Week Range:

$2.85

$3.94

52-Week Range:

$2.85

$12.00

Sana Biotechnology Inc Stock (SANA) Company Profile

Name

Sana Biotechnology Inc

Sector

Healthcare (1182)

Industry

Biotechnology (671)

Phone

(206) 701-7914

Address

188 EAST BLAINE STREET, SUITE 400, SEATTLE

Employee

328

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

SANA's Discussions on Twitter

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-25-23	Initiated	JMP Securities	Mkt Outperform
Sep-05-23	Initiated	Citigroup	Buy
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	BofA Securities	Buy
Mar-01-21	Initiated	Goldman	Neutral
Mar-01-21	Initiated	JP Morgan	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight

View All

Sana Biotechnology Inc Stock (SANA) Latest News

10:57 AM

Sana lowered to market perform by JMP over data uncertainty - MSN

10:57 AM

10:55 AM

Sana Biotechnology (NASDAQ:SANA) Sets New 12-Month Low After Analyst Downgrade - MarketBeat

10:55 AM

09:58 AM

HC Wainwright Issues Pessimistic Forecast for Sana Biotechnology (NASDAQ:SANA) Stock Price - MarketBeat

09:58 AM

09:47 AM

Sana Biotechnology stock hits 52-week low at $3.05 - Investing.com

09:47 AM

07:13 AM

Sana Biotechnology (NASDAQ:SANA) Rating Lowered to "Market Perform" at JMP Securities - MarketBeat

07:13 AM

03:51 AM

Vanguard Group Inc's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com

03:51 AM

Nov 04, 2024

Sana Biotechnology refocuses on autoimmune and diabetes therapies - Investing.com

Nov 04, 2024

Sana Biotechnology refocuses on autoimmune and diabetes therapies By Investing.com - Investing.com UK

Nov 04, 2024

Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & SAB Biotherapeutics (NASDAQ:SABS) - Defense World

Oct 21, 2024

Oct 18, 2024

Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Oct 18, 2024

Oct 16, 2024

Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts - Insider Monkey

Oct 16, 2024

Biotech stock tumbles after unexplained 1,446% gain - MSN

Oct 16, 2024

Oct 15, 2024